Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Peninsula Headlands LLC

Neither a doctor nor a teaching hospital

Research payments

$20,299,435

4,597 payments

Through program year 2025, Peninsula Headlands LLC is reported as receiving $20,299,435 in research payments, across 4,597 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $5,958,381 278
2024 Research $6,817,435 159
2023 Research $6,016,113 4,131
2022 Research $1,507,506 29

Breakdown

Who paid Research payments · program years 2022–2025
  1. Moderna TX, Inc. $8,224,389 4,254 payments
  2. Sanofi Pasteur Inc. $4,630,790 115 payments
  3. Eli Lilly and Company $2,846,563 21 payments
  4. Pfizer Inc. $2,247,449 123 payments
  5. AstraZeneca Pharmaceuticals LP $1,890,429 13 payments
  6. Sanofi US Services Inc. $435,788 50 payments
  7. Regeneron Pharmaceuticals, Inc. $21,053 20 payments
  8. Genentech, Inc. $2,974 1 payment
Studies the money was for Research payments · program years 2022–2025
  1. A Randomized, Observer-Blind, Active-Controlled Phase 3 Study to Investigate the Safety, Immunogenicity, and Relative Vaccine Efficacy of mRNA-1283.222 Administered as a Booster Dose Compared With mRNA-1273.222 in Participants Aged 12 Years and Older for the Prevention of COVID-19 $2,431,991 1,548 payments
  2. Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older $1,716,179 21 payments
  3. A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older $1,676,724 1,693 payments
  4. A Phase I/IIa, Randomized, Observer-blind Placebo-controlled Multi-arm Study to Evaluate the Safety and Immunogenicity of an RSV/hMPV Vaccine, in Adult Participants Aged 60 Years and Older $1,612,348 66 payments
  5. A Phase I Openlabel Randomized ActiveControlled Study in Adults to Characterize the Safety and Immunogenicity of AZD9838 Vaccine ARTEMIS C $1,114,215 3 payments
  6. A Phase 3, Randomized, Observer-blind, Active-controlled, Case-drivenStudy to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Seasonal Influenza Vaccine Compared with a Licensed Inactivated Seasonal Influenza Vaccine in Adults 50 Years of Age $994,026 7 payments
  7. A Master Phase 123 Protocol to Investigate the Safety Tolerability and Immunogenicity of Bivalent Bnt162b2 Rna Based Vaccine Candidates in Healthy Children $993,585 25 payments
  8. Phase 2 Study With Combination of Vemurafenib With Cobimetinib in B-Raf V600e/K Mutated Melanoma Patients to Normalize LDH and Optimize Nivolumab and Ipilimumab Therapy $840,388 3 payments
  9. A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $834,885 45 payments
  10. A Phase I/II, Randomized, Placebo-controlled Multi-arm Dose-finding Study to Evaluate the Safety and Immunogenicity of a RSV mRNA Vaccine Candidate With Either LNP CL-0059 or LNP CL-0137 in Adult Participants 18 to 50 Years of Age in a Sentinel Cohort and 60 Years and Older in Main and Booster Cohorts $757,425 47 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record